Vecata

Vecata Invest A/S is an investment companyinvestment company in Denmark managing the Bagger-Sorensen Group's investments in the venture segment. Founded 2003 in Vejle, Syddanmark, Denmark, this venture capital firm invests in early stage ventures. Its portfolio companies include Proxeon, Fluxome, Zoomio Holding, Anapa Biotech, and LiPlasome Pharma. As of February 2020, Vecata has made six investments. Their most recent investment was on Feb 2, 2009, when Proxeon raised $2.4M. Vecata has had three exits, the most notable of which include Fluxome, Proxeon, and Zoomio Holding. The company do not focus on specific industries.

Vecata Invest A/S is an investment company in Denmark managing the Bagger-Sorensen Group's investments in the venture segment. Founded 2003 in VejleVejle, Syddanmark, Denmark, this venture capital firm invests in early stage ventures. Its portfolio companies include Proxeon, Fluxome, Zoomio Holding, Anapa Biotech, and LiPlasome Pharma. As of February 2020, Vecata has made six investments. Their most recent investment was on Feb 2, 2009, when Proxeon raised $2.4M. Vecata has had three exits, the most notable of which include Fluxome, Proxeon, and Zoomio Holding. The company do not focus on specific industries.

Vecata Invest A/S is an investment company in Denmark managing the Bagger-Sorensen Group's investments in the venture segment. Founded 2003 in Vejle, Syddanmark, Denmark, this venture capital firm invests in early stage ventures. Its portfolio companies include Proxeon, Fluxome, Zoomio Holding, Anapa Biotech, and LiPlasome Pharma. As of February 2020, Vecata has made six investments. Their most recent investment was on Feb 2, 2009, when Proxeon raised $2.4M. Vecata has had three exits, the most notable of which include Fluxome, Proxeon, and Zoomio Holding. The company do not focus on specific industries.